200 related articles for article (PubMed ID: 36476377)
1. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice.
Qu Y; Chang L; Ma L; Wan X; Hashimoto K
Pharmacol Biochem Behav; 2023 Jan; 222():173500. PubMed ID: 36476377
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress.
Liu G; Ma L; Qu Y; Wan X; Xu D; Zhao M; Murayama R; Hashimoto K
Pharmacol Biochem Behav; 2023 Dec; 233():173659. PubMed ID: 37844631
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
Sekssaoui M; Bockaert J; Marin P; Bécamel C
Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
[TBL] [Abstract][Full Text] [Related]
4. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
[TBL] [Abstract][Full Text] [Related]
6. Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.
Hibicke M; Landry AN; Kramer HM; Talman ZK; Nichols CD
ACS Chem Neurosci; 2020 Mar; 11(6):864-871. PubMed ID: 32133835
[TBL] [Abstract][Full Text] [Related]
7. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
[TBL] [Abstract][Full Text] [Related]
8. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
10. The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.
Pogorelov VM; Rodriguiz RM; Roth BL; Wetsel WC
bioRxiv; 2023 Jun; ():. PubMed ID: 37333376
[TBL] [Abstract][Full Text] [Related]
11. Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.
Pędzich BD; Medrano M; Buckinx A; Smolders I; De Bundel D
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499610
[TBL] [Abstract][Full Text] [Related]
12. The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.
Pogorelov VM; Rodriguiz RM; Roth BL; Wetsel WC
Front Mol Biosci; 2023; 10():1233743. PubMed ID: 37900918
[TBL] [Abstract][Full Text] [Related]
13. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
[TBL] [Abstract][Full Text] [Related]
14. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
15. Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression.
Huang N; Hua D; Zhan G; Li S; Zhu B; Jiang R; Yang L; Bi J; Xu H; Hashimoto K; Luo A; Yang C
Pharmacol Biochem Behav; 2019 Jan; 176():93-100. PubMed ID: 30528936
[TBL] [Abstract][Full Text] [Related]
16. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
Banerjee AA; Vaidya VA
Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
[TBL] [Abstract][Full Text] [Related]
17. Psychedelic-inspired drug discovery using an engineered biosensor.
Dong C; Ly C; Dunlap LE; Vargas MV; Sun J; Hwang IW; Azinfar A; Oh WC; Wetsel WC; Olson DE; Tian L
Cell; 2021 May; 184(10):2779-2792.e18. PubMed ID: 33915107
[TBL] [Abstract][Full Text] [Related]
18. New investigational agents for the treatment of major depressive disorder.
Pochwat B; Krupa AJ; Siwek M; Szewczyk B
Expert Opin Investig Drugs; 2022 Oct; 31(10):1053-1066. PubMed ID: 35975761
[TBL] [Abstract][Full Text] [Related]
19. 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.
Quesseveur G; Repérant C; David DJ; Gardier AM; Sanchez C; Guiard BP
Exp Brain Res; 2013 Apr; 226(2):285-95. PubMed ID: 23411676
[TBL] [Abstract][Full Text] [Related]
20. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
Yang C; Shirayama Y; Zhang JC; Ren Q; Yao W; Ma M; Dong C; Hashimoto K
Transl Psychiatry; 2015 Sep; 5(9):e632. PubMed ID: 26327690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
